ATM-dependent phosphorylation of MEF2D promotes neuronal survival after DNA damage

Journal of Neuroscience

Volumn 34, Issue 13, 2014, Pages 4640-4653

  Chan, Shing Fai ^a   Sances, Sam ^a   Brill, Laurence M ^b   Okamoto, Shu Ichi ^a   Zaidi, Rameez ^a   McKercher, Scott R ^a   Akhtar, Mohd W ^a   Nakanishi, Nobuki ^a   Lipton, Stuart A ^a  

^a Aging   (United States)

^b BURNHAM INSTITUTE   (United States)

Author keywords

Ataxia telangiectasia; ATM; DNA damage; MEF2D; Neuronal survival; Phosphorylation

Indexed keywords

ATM PROTEIN; MYOCYTE ENHANCER FACTOR 2; MYOCYTE ENHANCER FACTOR 2D; PROTEIN BCL XL; SUPEROXIDE; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; LIQUID CHROMATOGRAPHY; MALE; MOUSE; NERVE CELL; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING;

ATAXIA TELANGIECTASIA; ATM; DNA DAMAGE; MEF2D; NEURONAL SURVIVAL; PHOSPHORYLATION;

ANIMALS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CELL SURVIVAL; CELLS, CULTURED; CEREBELLUM; DNA DAMAGE; ENZYME INHIBITORS; FEMALE; HEK293 CELLS; HUMANS; MALE; MEF2 TRANSCRIPTION FACTORS; MICE; MICE, KNOCKOUT; NEURONS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; SUPEROXIDES;

EID: 84897891808     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2510-12.2014     Document Type: Article

References (68)

1. Abraham RT (2001) Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev 15:2177-2196. CrossRef Medline
2. Bakkenist CJ, Kastan MB (2003) DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 42: 499-506. CrossRef Medline
3. Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, Shiloh Y, Crawley JN, Ried T, Tagle D, Wynshaw-Boris A (1996) Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86:159-171. CrossRef Medline
4. Barzilai A, Rotman G, Shiloh Y (2002) ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair 1:3-25. CrossRef Medline
5. Barzilai A, Biton S, Shiloh Y (2008) The role of the DNAdamage response in neuronal development, organization and maintenance. DNA Repair 7:1010-1027. CrossRef Medline
6. Biton S, Dar I, Mittelman L, Pereg Y, Barzilai A, Shiloh Y (2006) Nuclear ataxia-telangiectasia mutated (ATM) mediates the cellular response to DNA double strand breaks in human neuron-like cells. J Biol Chem 281: 17482-17491. CrossRef Medline
7. Boise LH, González-García M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nuñez G, Thompson CB (1993) Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608. CrossRef Medline
8. Breitbart RE, Liang CS, Smoot LB, Laheru DA, Mahdavi V, Nadal-Ginard B (1993) A fourth human MEF2 transcription factor, h MEF2D, is an early marker of themyogenic lineage. Development 118:1095-1106. Medline
9. Brill LM, Motamedchaboki K, Wu S, Wolf DA (2009) Comprehensive proteomic analysis of Schizosaccharomyces pombe by two-dimensional HPLC-tandem mass spectrometry. Methods 48:311-319. CrossRef Medline
10. Chen J, Graham SH, Nakayama M, Zhu RL, Jin K, Stetler RA, Simon RP (1997) Apoptosis repressor genes Bcl-2 and Bcl-x-long are expressed in the rat brain following global ischemia. J Cereb Blood Flow Metab 17:2-10. CrossRef Medline
11. Falck J, Coates J, Jackson SP (2005) Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNAdamage. Nature 434:605-611. CrossRef Medline
12. Flavell SW, Greenberg ME (2008) Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system. Annu Rev Neurosci 31:563-590. CrossRef Medline
13. Flavell SW, Cowan CW, Kim TK, Greer PL, Lin Y, Paradis S, Griffith EC, Hu LS, Chen C, Greenberg ME (2006) Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science 311:1008-1012. CrossRef Medline
14. Frankowski H, Missotten M, Fernandez PA, Martinou I, Michel P, Sadoul R., Martinou JC (1995) Function and expression of the Bcl-x gene in the developing and adult nervous system. Neuroreport 6:1917-1921. CrossRef Medline
15. Garinis GA, van der Horst GT, Vijg J, Hoeijmakers JH (2008) DNA damage and ageing: new-age ideas for an age-old problem. Nat Cell Biol 10:1241-1247. CrossRef Medline
16. Gaudilliere B, Shi Y, Bonni A (2002) RNA interference reveals a requirement for myocyte enhancer factor 2A in activity-dependent neuronal survival. J Biol Chem 277:46442-46446. CrossRef Medline
17. González-García M, García I, Ding L, O'Shea S, Boise LH, Thompson CB, Núñez G (1995) Bclx is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc Natl Acad Sci U S A 92:4304-4308. CrossRef Medline
18. Grillot DA, González-García M, Ekhterae D, Duan L, Inohara N, Ohta S, Seldin MF, Nuñez G (1997) Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene. J Immunol 158:4750-4757. Medline
19. Guo Z, Kozlov S, Lavin MF, Person MD, Paull TT (2010) ATMactivation by oxidative stress. Science 330:517-521. CrossRef Medline
20. Gupta S, Campbell D, Dérijard B, Davis RJ (1995) Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267: 389-393. CrossRef Medline
21. Han J, Jiang Y, Li Z, Kravchenko VV, Ulevitch RJ (1997) Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 386:296-299. CrossRef Medline
22. Hickson I, Zhao Y, Richardson CJ, Green SJ, Martin NM, Orr AI, Reaper PM, Jackson SP, Curtin NJ, Smith GC (2004) Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res 64:9152-9159. CrossRef Medline
23. Ikeshima H, Imai S, Shimoda K, Hata J, Takano T (1995) Expression of a MADS box gene, MEF2D, in neurons of the mouse central nervous system: implication of its binary function in myogenic and neurogenic cell lineages. Neurosci Lett 200:117-120. CrossRef Medline
24. Kamer I, Sarig R, Zaltsman Y, Niv H, Oberkovitz G, Regev L, Haimovich G, Lerenthal Y, Marcellus RC, Gross A (2005) Proapoptotic BID is an ATM effector in the DNA-damage response. Cell 122:593-603. CrossRef Medline
25. Kanu N, Penicud K, Hristova M, Wong B, Irvine E, Plattner F, Raivich G, Behrens A (2010) The ATM cofactor ATMIN protects against oxidative stress and accumulation of DNA damage in the aging brain. J Biol Chem 285:38534-38542. CrossRef Medline
26. Khanna KK, Jackson SP (2001) DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 27:247-254. CrossRef Medline
27. Khanna KK, Lavin MF, Jackson SP, Mulhern TD (2001) ATM, a central controller of cellular responses to DNA damage. Cell Death Differ 8:1052-1065. CrossRef Medline
28. Kim ST, Lim DS, Canman CE, Kastan MB (1999) Substrate specificities and identification of putative substrates of ATMkinase family members. J Biol Chem 274:37538-37543. CrossRef Medline
29. Kim Y, Phan D, van Rooij E, Wang DZ, McAnally J, Qi X, Richardson JA, Hill JA, Bassel-Duby R, Olson EN (2008) The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice. J Clin Invest 118: 124-132. CrossRef Medline
30. Kozlov SV, Graham ME, Peng C, Chen P, Robinson PJ, Lavin MF (2006) Involvement of novel autophosphorylation sites in ATM activation. EMBO J 25:3504-3514. CrossRef Medline
31. Lavin MF, Gueven N, Bottle S, Gatti RA (2007) Current and potential therapeutic strategies for the treatment of ataxia-telangiectasia. Br Med Bull 81:129-147. CrossRef Medline
32. Leifer D, Krainc D, Yu YT, McDermott J, Breitbart RE, Heng J, Neve RL, Kosofsky B, Nadal-Ginard B, Lipton SA (1993) MEF2C, a MADS/ MEF2-family transcription factor expressed in a laminar distribution in cerebral cortex. Proc Natl Acad Sci U S A 90:1546-1550. CrossRef Medline
33. Levi G, Aloisi F, Ciotti MT, Gallo V (1984) Autoradiographic localization and depolarization-induced release of acidic amino acids in differentiating cerebellar granule cell cultures. Brain Res 290:77-86. CrossRef Medline
34. Li J, Chen J, Ricupero CL, Hart RP, Schwartz MS, Kusnecov A, Herrup K (2012) Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia. Nat Med 18:783-790. CrossRef Medline
35. Li M, Linseman DA, Allen MP, Meintzer MK, Wang X, Laessig T, Wierman ME, Heidenreich KA (2001) Myocyte enhancer factor 2A and 2D undergo phosphorylation and caspase-mediated degradation during apoptosis of rat cerebellar granule neurons. J Neurosci 21:6544-6552. Medline
36. Li Z, McKercher SR, Cui J, Nie Z, Soussou W, Roberts AJ, Sallmen T, Lipton JH, Talantova M, Okamoto S, Lipton SA (2008) Myocyte enhancer factor 2C as a neurogenic and antiapoptotic transcription factor in murine embryonic stem cells. J Neurosci 28:6557-6568. CrossRef Medline
37. Lin X, Shah S, Bulleit RF (1996) The expression of MEF2 genes is implicated in CNS neuronal differentiation. Brain Res. Mol Brain Res 42:307-316. CrossRef Medline
38. Liu T, Hannafon B, Gill L, Kelly W, Benbrook D (2007) Flex-Hets differentially induce apoptosis in cancer over normal cells by directly targeting mitochondria. Mol Cancer Ther 6:1814-1822. CrossRef Medline
39. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) Method. Methods 25:402-408. CrossRef Medline
40. Lyons GE, Micales BK, Schwarz J, Martin JF, Olson EN (1995) Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation. J Neurosci 15:5727-5738. Medline
41. Ma L, Tao Y, Duran A, Llado V, Galvez A, Barger JF, Castilla EA, Chen J, Yajima T, Porollo A, Medvedovic M, Brill LM, Plas DR, Riedl SJ, Leitges M, Diaz-Meco MT, Richardson AD, Moscat J (2013) Control of nutrient stress-induced metabolic reprogramming by PKC in tumorigenesis. Cell 152:599-611. CrossRef Medline
42. McKinnon PJ (2004) ATMand ataxia telangiectasia. EMBORep 5:772-776. CrossRef Medline
43. McKinsey TA, Zhang CL, Olson EN (2002) MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem Sci 27:40-47. CrossRef Medline
44. Naya FJ, Olson E (1999) MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation. Curr Opin Cell Biol 11:683-688. CrossRef Medline
45. Okamoto S, Krainc D, Sherman K, Lipton SA (2000) Antiapoptotic role of the p38 mitogen-activated protein kinase-myocyte enhancer factor 2 transcription factor pathway during neuronal differentiation. Proc Natl Acad Sci U S A 20:7561-7566. CrossRef Medline
46. Okamoto S, Li Z, Ju C, Scholzke MN, Mathews E, Cui J, Salvesen GS, Bossy-Wetzel E, Lipton SA (2002) Dominant-interfering forms of MEF2 generated by caspase cleavage contribute to NMDA-induced neuronal apoptosis. Proc Natl Acad Sci U S A 99:3974-3979. CrossRef Medline
47. O'Neill T, Dwyer AJ, Ziv Y, Chan DW, Lees-Miller SP, Abraham RH, Lai JH, Hill D, Shiloh Y, Cantley LC, Rathbun GA (2000) Utilization of oriented peptide libraries to identify substrate motifs selected by ATM. J Biol Chem 275:22719-22727. CrossRef Medline
48. Pulipparacharuvil S, Renthal W, Hale CF, Taniguchi M, Xiao G, Kumar A, Russo SJ, Sikder D, Dewey CM, Davis MM, Greengard P, Nairn AC, Nestler EJ, Cowan CW (2008) Cocaine regulates MEF2 to control synaptic and behavioral plasticity. Neuron 59:621-633. CrossRef Medline
49. Reichenbach J, Schubert R, Schindler D, Müller K, Böhles H, Zielen S (2002) Elevated oxidative stress in patients with ataxia telangiectasia. Antioxid Redox Signal 4:465-469. CrossRef Medline
50. Robinson KM, Janes MS, Beckman JS (2008) The selective detection of mitochondrial superoxide by live cell imaging. Nat Protoc 3:941-947. CrossRef Medline
51. Rotman G, Shiloh Y (1997) Ataxia-telangiectasia: is ATM a sensor of oxidative damage and stress? Bio Essays 19:911-917. CrossRef Medline
52. Rotman G, Shiloh Y (1998) ATM: from gene to function. Hum Mol Genet 7:1555-1563. CrossRef Medline
53. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3:1101-1108. CrossRef Medline
54. Schneider JW, Gao Z, Li S, Farooqi M, Tang TS, Bezprozvanny I, Frantz DE, Hsieh J (2008) Small-molecule activation of neuronal cell fate. Nat Chem Biol 4:408-410. CrossRef Medline
55. Shalizi A, Lehtinen M, Gaudilliere B, Donovan N, Han J, Konishi Y, Bonni A (2003) Characterization of a neurotrophin signaling mechanism that mediates neuron survival in a temporally specific pattern. J Neurosci 23:7326-7336. Medline
56. Shalizi A, Gaudillière B, Yuan Z, Stegmüller J, Shirogane T, Ge Q, Tan Y, Schulman B, Harper JW, Bonni A (2006) A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation. Science 311: 1012-1017. CrossRef Medline
57. She H, Yang Q, Shepherd K, Smith Y, Miller G, Testa C, Mao Z (2011) Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients. J Clin Invest 121:930-940. CrossRef Medline
58. Shiloh Y (2003) ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 3:155-168. CrossRef Medline
59. Shiloh Y (2006) The ATM-mediated DNA-damage response: taking shape. Trends Biochem Sci 31:402-410. CrossRef Medline
60. Stern N, Hochman A, Zemach N, Weizman N, Hammel I, Shiloh Y, Rotman G, Barzilai A (2002) Accumulation of DNA damage and reduced levels of nicotine adenine dinucleotide in the brains of Atm-deficient mice. J Biol Chem 277:602-608. CrossRef Medline
61. Swaney DL, McAlister GC, Coon JJ (2008) Decision tree-driven tandem mass spectrometry for shotgun proteomics. Nat Methods 5:959-964. CrossRef Medline
62. Syka JE, Coon JJ, Schroeder MJ, Shabanowitz J, Hunt DF (2004) Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. Proc Natl Acad Sci U S A 101:9528-9533. CrossRef Medline
63. Traven A, Heierhorst J (2005) SQ/TQ cluster domains: concentrated ATM/ ATR kinase phosphorylation site regions in DNA-damage-response proteins. Bioessays 27:397-407. CrossRef Medline
64. Uziel T, Lerenthal Y, Moyal L, Andegeko Y, Mittelman L, Shiloh Y (2003) Requirement of the MRN complex for ATM activation by DNA damage. EMBO J 22:5612-5621. CrossRef Medline
65. Wilson DM 3rd, Bianchi C (1999) Improved immunodetection of nuclear antigens after sodium dodecyl sulfate treatment of formaldehyde-fixed cells. J Histochem Cytochem 47:1095-1100. CrossRef Medline
66. Wu ZH, Shi Y, Tibbetts RS, Miyamoto S (2006) Molecular linkage between the kinase ATM and NF-kappa B signaling in response to genotoxic stimuli. Science 311:1141-1146. CrossRef Medline
67. Zinkel SS, Hurov KE, Ong C, Abtahi FM, Gross A, Korsmeyer SJ (2005) A role for proapoptotic BID in the DNA-damage response. Cell 122:579-591. CrossRef Medline
68. Ziv Y, Banin S, Lim DS, Canman CE, Kastan MB, Shiloh Y (2000) Expression and assay of recombinant ATM. Methods Mol Biol 99:99-108. CrossRef Medline